Level A· Stronger Clinical EvidenceSystematic ReviewPubMed

Osteoradionecrosis of the Jaw-Thinking Outside the Box, a Review of Emerging Treatment Paradigms.

Pak KY., Nunez A., Patel H., Lee JK., Epstein JB., Ho AS.

Systematic Review on Face & Skin, published in J Craniofac Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
J Craniofac Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40737586
DOI
10.1097/SCS.0000000000011506

Abstract (original English)

Osteoradionecrosis (ORN) of the jaw occurs due to the damaging effects of ionizing radiation used in the treatment of head and neck cancer, including oral cavity or oropharyngeal, nasopharyngeal, and salivary gland sites. Medical treatments for ORN have limited effectiveness in advanced cases, often necessitating resection of affected bone with microvascular reconstruction using a bone-containing free flap in advanced cases. Surgical innovations in minimally invasive free fascial and periosteal flaps have shown promise in restoring blood supply and halting disease progression, although they are not universally successful. In addition, novel cell-mediated regenerative treatments for osteoradionecrosis, including the use of adipose-derived and bone marrow-derived stem cells in craniomaxillofacial defects, have also demonstrated potential. The management of intermediate ORN remains a subject of debate, leading to a review of novel approaches to address this challenging condition. This review evaluates the efficacy of a range of treatment options, including new cell-based treatments for osteoradionecrosis (ORN) by analyzing literature from Medline, PubMed, and Embase databases using search terms such as “osteoradionecrosis,†“stem cells,†“therapy,†“radiation,†and “reconstructive surgery.†Relevant papers for this review were triaged by abstract and title, categori

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
OsteoradionecrosisJaw DiseasesHead and Neck NeoplasmsPlastic Surgery ProceduresHumansAnimalsAdipocytesBone Marrow CellsRegenerative MedicineSurgical Flaps

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research